EVOTAZ Approved By FDA

EVOTAZ

Today the FDA approved Bristol-Myers Squibb Company’s new HIV antiretroviral combination EVOTAZ. Evotaz is a combination of atazanavir and Cobicistat and is approved for the treatment of HIV-1 infection in adults in combination with other antiretroviral agents. Evotaz is a once daily pill that has shown in studies to suppress HIV through 48 weeks. The…

Continue Reading →

Mich’s Monday Mantra “Breathe In The Day And Enjoy”

DPSunset12

Mich’s Monday Mantra today is coming to you above Strands Beach in Dana Point California as we bear witness to one of the most magnificent sunsets I have ever seen. Our Mantra today is “Breathe In The day and Enjoy” if you enjoyed this mantra pay it forward and share it with a friend….Namaste

Continue Reading →

Mich’s Monday Mantra Coming To MichRx Consulting

Mich_s_Monday_Mantra

For the past few years I have been recording videos “Mich’s Monday Mantra” that are posted on YouTube and are for my patient website HIVThrive Mich’s Monday Mantra is an inspirational mantra that has given many of my patients peace and inspiration especially during times of stress, fear and anxiety Your well being and Mindset…

Continue Reading →

California Pharmacists Report Progress in Move To Broaden Scope of Practice

PharmacistConsult

by George Lauer, California Healthline Features Editor, California Healthline, Tuesday, January 20, 2015 Pharmacists are about to finish one phase and start another in the march toward broadening their scope of practice in California to include more primary care services. Using new guidelines created in a bill signed into state law about a year ago,…

Continue Reading →

Brown’s Budget Includes Funding for Costly Hepatitis C Treatment

California Healthline, Tuesday, January 13, 2015 Gov. Jerry Brown’s (D) proposed fiscal year 2015-2016 budget allocates about $300 million for high-cost drugs, including expensive medication to treat hepatitis C, Capital Public Radio’s “KXJZ News” reports (Bartolone, “KXJZ News,” Capital Public Radio, 1/12). Background on Budget Plan Last week, Brown released his $113.3 billion FY 2015-2016…

Continue Reading →

Officials Say Hepatitis C Drug Too Pricey To Give to All Calif. Inmates

Sovaldi

California Healthline, Tuesday, October 21, 2014 A new study finds that Gilead’s $1,000-per-pill hepatitis C drug could be worth the cost to treat prisoners with the disease, but prison and jail officials in California say the drug is too expensive to use on all inmates who need it, the San Francisco Business Times‘ “BiotechSF” reports.

Continue Reading →

How Do You Use Facebook For Your Marketing? Some Tips To Save YOUR Content

FB Unpublished

I wanted to share my recent experience with Facebook with you as I think there are some very important lessons you can learn when using your Facebook page for your Marketing. As you know Facebook works on complicated algorithms that computer geniuses come up with as they sit at their computers each day. On Tuesday…

Continue Reading →

Michelle to Speak at Marketing – What’s Happening Workshop in Baltimore

IMG_3857

The American College of Apothecaries is holding their Marketing –What’s Happening Workshop in Baltimore.MD October 31st-November 1, 2014 Michelle is one of the speakers at the event, so this is the place to be if you’re interested in venturing into a Specialty at your pharmacy or you want to expand your current specialty. Check out…

Continue Reading →

High-Priced Drug Makes Its Way Into California Prisons

by George Lauer, California Healthline Features Editor, California Healthline, Monday, August 25, 2014 While lawmakers in Congress and policymakers in Sacramento grapple with how to pay for — and perhaps regulate the cost of — high priced new drugs, an effective and expensive new treatment for hepatitis C continues to make inroads in California. California…

Continue Reading →

Can the ACA Solve Staggering Prescription Drug Prices?

by Anthony Wilson, California Healthline Contributing Editor, California Healthline, Wednesday, August 20, 2014 Last December, FDA approved the hepatitis C treatment Sovaldi, giving it a coveted breakthrough therapy designation that allowed its maker, Gilead Sciences, to fast-track its approval. Observers hailed the drug as a “game changer” because it combined a high cure rate with…

Continue Reading →

Page 2 of 9